Placeholder Banner

BIO's Testimony in Opposition to Maryland's House Bill 666

February 27, 2017
Download Full Comments Below
BIO Testimony On Maryland HB 666 Feb 23 2016 FINAL
Full Testimony (PDF)
Discover More
On behalf of its member organizations, Biotechnology Innovation Organization (“BIO”) respectfully submits this Comment in response to the United States Patent and Trademark Office’s (the “Patent Office” or “PTO”) February 13, 2024 Request for…
BIO comments on a proposed rule to restrict planting of GE organisms on national wildlife refuge lands. 
BIO submits comments on the MDH’s proposed regulations regarding Drugs of Substantial Public Interest: Draft Methodology for Public Comment as required in statute by the Prescription Drug Price Transparency Act.